SKU: 0328ATC

SF-295 Human Epithelial Cells

Tumor Cell Lines > Nerve Tumor Cell Lines

Product Type: Human Nerve Tumors Cell Lines

Species: Human

Cell Type: Epithelial Cells

Source Organ: Other

Inquire about this product

Delivery and Shipping

Ship on dry ice.

Cell Name: SF-295

Tissue: CNS. 5N+/-, Near-pentaploid 115+/- (104-126).

  • Description
    SF-295 is a human glioblastoma cell line derived from a left frontal lobe tumor of a 67-year-old Caucasian female patient. These cells exhibit glial-like morphology and are hypertriploid, with a near-pentaploid chromosome number ranging from 104 to 126. They are homozygous for mutations in tumor suppressor genes PTEN and TP53 and possess a TERT promoter mutation (C228T), commonly associated with glioblastoma multiforme (GBM). SF-295 cells lack expression of glial markers GFAP and glutamine synthetase but express neurofibromin-1 (NF1). In vivo studies have shown that SF-295 cells are non-tumorigenic in athymic mice. This cell line has been extensively utilized in preclinical research, including studies on chemotherapeutic agents like temozolomide and BCNU, where it demonstrated significant tumor growth delay and synergistic effects when used in combination therapies. SF-295 is also part of the NCI-60 cancer cell line panel, making it a valuable model for investigating GBM biology and therapeutic responses.
  • Product Name
    SF-295
  • Product Type
    Human Nerve Tumors Cell Lines
  • Species
    Human
  • Cell Type
    Epithelial
  • Growth Conditions
    37 °C, 5% CO2
  • Application
    The SF-295 cell line has broad utility in brain cancer research, particularly focused on glioblastoma multiforme (GBM), the most aggressive and malignant form of brain cancer. It serves as a standard brain tumor model in various cell line panel projects, making it invaluable in contemporary research. SF-295 is highly utilized in studies investigating chemotherapeutic treatments for glioblastoma, providing a valuable cellular model for assessing the impact of drugs and molecular modulators on glioblastomas. Through these s, SF-295 contributes significantly to advancing our understanding and developing new treatment strategies for this devastating disease.
  • Size/Quantity
    1 vial
  • Recommended Medium And Supplement

    RPMI 1640 + 10% FBS
  • Shipping Conditions
    Dry Ice
  • Storage
    Liquid Nitrogen
  • Biosafety Level
    1

Payment & Security

Payment methods

    Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

    Product inquiry

    Tell us what you need and our team will get back to you with pricing and availability.

    • Visit our support center

      Expert help & advice

    • Check your order status

      Updates & tracking

    • Returns & exchanges

      All you need to know

    • Price-match guarantee

      Our promise to you